Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Neve

Showing results (21-30 of 151) with videos related to

Pageof 16
Sort By:
The American Journal of Cardiology|April 25, 1986
Effects of chronic administration of agonists and antagonists on the density of beta-adrenergic receptorsK A Neve, P B Molinoff
Molecular Pharmacology|December 16, 1997
Constitutive activity of a chimeric D2/D1 dopamine receptorL B Kozell, K A Neve
Biochemical Pharmacology|August 15, 1988
Development and characterization of anti-spiroperidol antibodiesK A Neve, D E Casey
Pharmacology & Therapeutics|June 1, 2005
Sensitization of adenylate cyclase by Galpha i/o-coupled receptorsVal J Watts, Kim A Neve
Biochemical Society Transactions|February 1, 1995
Four ways of being an agonist: multiple sequence determinants of efficacy at D2 dopamine receptorsK A Neve, B L Wiens
Neuroscience Letters|April 20, 1984
The effects of denervation and chronic haloperidol treatment on neostriatal dopamine receptor density are not additive in the ratK A Neve, J F Marshall
Molecular Pharmacology|August 1, 1997
Activation of type II adenylate cyclase by D2 and D4 but not D3 dopamine receptorsV J Watts, K A Neve
Molecular Pharmacology|October 1, 1996
Sensitization of endogenous and recombinant adenylate cyclase by activation of D2 dopamine receptorsV J Watts, K A Neve
Molecular Pharmacology|August 1, 1986
Turnover of beta 1- and beta 2-adrenergic receptors after down-regulation or irreversible blockadeK A Neve, P B Molinoff
Acta Physiologica (Oxford, England)|November 22, 2011
Osteocytes: central conductors of bone biology in normal and pathological conditionsA Neve, A Corrado, F P Cantatore
Pageof 16

Showing results (21-30 of 151) with videos related to

Sort By:
Pageof 16
The American Journal of Cardiology|April 25, 1986
Effects of chronic administration of agonists and antagonists on the density of beta-adrenergic receptorsK A Neve, P B Molinoff
Molecular Pharmacology|December 16, 1997
Constitutive activity of a chimeric D2/D1 dopamine receptorL B Kozell, K A Neve
Biochemical Pharmacology|August 15, 1988
Development and characterization of anti-spiroperidol antibodiesK A Neve, D E Casey
Pharmacology & Therapeutics|June 1, 2005
Sensitization of adenylate cyclase by Galpha i/o-coupled receptorsVal J Watts, Kim A Neve
Biochemical Society Transactions|February 1, 1995
Four ways of being an agonist: multiple sequence determinants of efficacy at D2 dopamine receptorsK A Neve, B L Wiens
Neuroscience Letters|April 20, 1984
The effects of denervation and chronic haloperidol treatment on neostriatal dopamine receptor density are not additive in the ratK A Neve, J F Marshall
Molecular Pharmacology|August 1, 1997
Activation of type II adenylate cyclase by D2 and D4 but not D3 dopamine receptorsV J Watts, K A Neve
Molecular Pharmacology|October 1, 1996
Sensitization of endogenous and recombinant adenylate cyclase by activation of D2 dopamine receptorsV J Watts, K A Neve
Molecular Pharmacology|August 1, 1986
Turnover of beta 1- and beta 2-adrenergic receptors after down-regulation or irreversible blockadeK A Neve, P B Molinoff
Acta Physiologica (Oxford, England)|November 22, 2011
Osteocytes: central conductors of bone biology in normal and pathological conditionsA Neve, A Corrado, F P Cantatore
Pageof 16